Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA and Genentech issue warning on Avastin

Aug. 18, 2004

New HSP90 inhibitors and their use in cancer and other disorders

Aug. 18, 2004

Swiss approval for Femara as extended adjuvant treatment

Aug. 18, 2004

Combined immunostimulatory treatment enhances antitumor activity in vivo

Aug. 18, 2004

NeuroSearch and TopoTarget collaborate on Endovion development

Aug. 17, 2004

Spectrum acquires North American, Indian rights to D-631153

Aug. 17, 2004

Novartis exercises option to Vernalis' lead Hsp90 oncology program

Aug. 16, 2004

Pharmacia presents new CDK inhibitors

Aug. 16, 2004

European orphan drug designation for TheraCIM hR3

Aug. 16, 2004

Array BioPharma and QLT collaborate in cancer therapeutics discovery

Aug. 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...